Outcomes of autologous HCT and CD19 CAR-T in diffuse large B-cell lymphoma first complete remissiom patients.
Study #: LY22-01a
Study Status: Published
Autologous transplant vs. CAR-T therapy in patients with DLBCL treated while in complete remission.
Shadman M, Ahn KW, Kaur M, Lekakis L, Beitinjaneh A, Iqbal M, Ahmed N, Hill B, Hossain NM, Riedell P, Gopal AK, Grover N, Frigault M, Brammer J, Ghosh N, Merryman R, Lazaryan A, Ram R, Hertzberg M, Savani B, Awan F, Khimani F, Ahmed S, Kenkre VP, Ulrickson M, Shah N, Kharfan-Dabaja MA, Herrera A, Sauter C, Hamadani M.
Blood Cancer Journal. 2024, Jul 08: 14(1): 14(1):108. doi: 10.1038/s41408-024-01084-w. Epub 2024, Jul 08. PMCID:PMC11231252.
PMID: 38977682
Abstract